Strain AI vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose Strain AI if…
Choose Strain AI if you need immediate, on-device AI analysis of cardiac ultrasound images to quantitatively assess heart function. This tool is ideal for cardiologists and sonographers requiring real-time Global Longitudinal Strain (GLS) measurements to diagnose and monitor conditions like heart failure or cardiotoxicity in adult patients during an echocardiogram.
View Strain AI →Choose LINQ II Insertable Cardiac Monitor if…
Choose LINQ II Insertable Cardiac Monitor if you require long-term, continuous heart rhythm monitoring to detect and diagnose infrequent or paroxysmal arrhythmias. This device is best suited for patients experiencing unexplained syncope, palpitations, or cryptogenic stroke, offering up to 4.5 years of AI-powered monitoring and remote data transmission for comprehensive rhythm analysis in both adult and pediatric patients.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Strain AI | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Deployment | API, Integrations with POS and menu sync platforms (Dutchie, Leafly, Weedmaps, Jane POS, Treez) | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Strain AITool A's on-device AI and offline operation for real-time ultrasound analysis streamline immediate clinical workflows, offering a direct and efficient user experience for physicians. While Tool B provides remote monitoring convenience, it involves patient interaction with a device and app, adding a layer of complexity for the overall system. Therefore, Tool A is slightly more straightforward for the clinician's immediate diagnostic task.
Clinical Value
LINQ II Insertable Cardiac MonitorTool B offers long-term, continuous heart rhythm monitoring for up to 4.5 years, including a pediatric indication, with AI algorithms significantly reducing false alerts and accurately predicting AFib risk. This provides sustained diagnostic and management value for chronic arrhythmias. Tool A provides immediate, quantitative diagnostic insights for heart function, but Tool B's extended monitoring and proactive risk stratification offer a broader and more enduring clinical impact.
Pricing & Value
TieBoth tools lack transparent public pricing, with information indicating that pricing is negotiated at an enterprise level. Without access to specific cost data or comparative cost-effectiveness studies, it is impossible to definitively determine which tool offers superior value.
Enterprise Readiness
LINQ II Insertable Cardiac MonitorMedtronic (Tool B) is a globally recognized medical device leader with a long history, a vast customer base exceeding one million patients, and explicit targeting of all health system sizes. This established infrastructure and market penetration demonstrate a significantly higher level of enterprise readiness compared to Exo (Tool A), a newer company.
Innovation
LINQ II Insertable Cardiac MonitorTool B's integration of AI into an insertable, long-term cardiac monitor for enhanced accuracy, false alert reduction, remote programming, and predictive capabilities for AFib risk represents a comprehensive and impactful innovation in continuous patient monitoring. While Tool A's real-time, on-device AI for GLS on a handheld ultrasound is innovative for point-of-care diagnostics, Tool B's system offers a broader, proactive approach to managing chronic cardiac conditions.
Support & Docs
LINQ II Insertable Cardiac MonitorMedtronic (Tool B), as a large, established global medical device company, provides extensive and well-structured support, including dedicated patient and technical services, comprehensive manuals, and patient education materials. While Exo (Tool A) offers documentation, Medtronic's scale and established infrastructure suggest a more robust and globally accessible support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Strain AI | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Name | Strain AI | LINQ II Insertable Cardiac Monitor |
| Company | Exo | Medtronic |
| Primary Function | AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients. | Advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. |
| Primary AI Application | Analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS). | AccuRhythmu2122 AI algorithms for enhanced accuracy and innovative PVC detection algorithm. |
| Target Patient Population | adult patients | Pediatric indication (ages 2+) |
| Key Monitoring/Analysis Capability | Analyzes cardiac ultrasound images; measures Global Longitudinal Strain (GLS); provides quantitative strain measurements. | Up to 4.5 years of continuous heart rhythm monitoring; remote programming capability; MRI compatibility (1.5 and 3.0T). |
Videos
Demos, reviews, and walkthroughs featuring Strain AI and LINQ II Insertable Cardiac Monitor.